| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity | [1]Yaning Gao, [2]Wanbo Tai, [3]Xinyi Wang, [4]Shibo Jiang, [5]Asim K. Debnath, [6]Lanying Du, [7]Shizhong Chen [Full author list] | BMC Biology [missing] | DOI: 10.1186/S12915-022-01344-W [ORCID]
| Dengue virus [missing] | 2022-06-15 | Shibo Jiang (Q89470665; 28 items)
|
| Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks | [1]Miao Cao, [2]Xiaojie Su, [3]Shibo Jiang [Full author list] | Stem Cell Reports [missing] | DOI: 10.1016/J.STEMCR.2020.12.010 [ORCID]
| COVID-19 pandemic [missing] | 2021-03-01 | Shibo Jiang (Q88118974; 321 items)
|
| Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics | [1]Shan Su, [2]Qian Wang, [3]Shibo Jiang [Full author list] | Clinical and translational medicine [missing] | DOI: 10.1002/CTM2.284 [ORCID]
PubMed: 33463059 [ORCID]
| pandemic [missing]; mutation [missing]; COVID-19 pandemic [missing]; SARS-CoV-2 [missing]; COVID-19 [missing]; COVID-19 vaccine [missing] | 2021-01-01 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine | [1]Wanbo Tai, [2]Lei He, [3]Xiujuan Zhang, [4]Jing Pu, [5]Denis Voronin, [6]Shibo Jiang, [7]Yusen Zhou, [8]Lanying Du [Full author list] | Cellular and Molecular Immunology [missing] | DOI: 10.1038/S41423-020-0400-4 [ORCID]
PubMed: 32203189 [ORCID]
| vaccine [missing]; Coronaviridae [missing]; COVID-19 [missing] | 2020-03-19 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion | [1]Shuai Xia, [2]Meiqin Liu, [3]Chao Wang, [4]Wei Xu, [5]Qiaoshuai Lan, [6]Siliang Feng, [7]Feifei Qi, [8]Linlin Bao, [9]Lanying Du, [10]Shuwen Liu, [11]Chuan Qin, [12]Fei Sun, [13]Zhengli Shi, [14]Yun Zhu, [15]Shibo Jiang, [16]Lu Lu [Full author list] | bioRxiv [missing] | DOI: 10.1101/2020.03.09.983247 [ORCID]
| COVID-19 pandemic [missing]; SARS-CoV-2 [missing]; COVID-19 [missing] | 2020-03-12 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Development of oncolytic virotherapy: from genetic modification to combination therapy | [1]Qiaoshuai Lan, [2]Shuai Xia, [3]Qian Wang, [4]Wei Xu, [5]Haiyan Huang, [6]Shibo Jiang, [7]Lu Lu [Full author list] | Frontiers of medicine [missing] | DOI: 10.1007/S11684-020-0750-4 [ORCID]
PubMed: 32146606 [ORCID]
| | 2020-03-07 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| A distinct name is needed for the new coronavirus | [1]Shibo Jiang, [2]Zhengli Shi, [3]Yuelong Shu, [4]Jingdong Song, [5]George F Gao, [6]Wenjie Tan, [7]Deyin Guo [Full author list] | The Lancet [missing] | DOI: 10.1016/S0140-6736(20)30419-0 [ORCID]
PubMed: 32087125 [ORCID]
| Coronaviridae [missing] | 2020-02-19 | Shibo Jiang (Q88118974; 321 items)
|
| Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein | [1]Shuai Xia, [2]Yun Zhu, [3]Meiqin Liu, [4]Qiaoshuai Lan, [5]Wei Xu, [6]Yanling Wu, [7]Tianlei Ying, [8]Shuwen Liu, [9]Zhengli Shi, [10]Shibo Jiang, [11]Lu Lu [Full author list] | Cellular and Molecular Immunology [missing] | DOI: 10.1038/S41423-020-0374-2 [ORCID]
PubMed: 32047258 [ORCID]
| structural biology [missing]; SARS-CoV-2 [missing]; COVID-19 [missing]; spike glycoprotein [SARS-CoV-2] [missing] | 2020-02-11 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome | [1]Shibo Jiang, [2]Shuai Xia, [3]Tianlei Ying, [4]Lu Lu [Full author list] | Cellular and Molecular Immunology [missing] | DOI: 10.1038/S41423-020-0372-4 [ORCID]
PubMed: 32024976 [ORCID]
| SARS-CoV-2 [missing]; COVID-19 [missing] | 2020-02-05 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell | [1]Chen Hua, [2]Yun Zhu, [3]Congquan Wu, [4]Lulu Si, [5]Qian Wang, [6]Long Sui, [7]Shibo Jiang [Full author list] | Frontiers in Microbiology [missing] | DOI: 10.3389/FMICB.2019.02188 [ORCID]
PubMed: 31611852 [ORCID]
| | 2019-09-26 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Design and Biological Evaluation of m-Xylene Thioether-Stapled Short Helical Peptides Targeting the HIV-1 gp41 Hexameric Coiled-Coil Fusion Complex | [1]Guangpeng Meng, [2]Jing Pu, [3]Yue Li, [4]Aixin Han, [5]Yangli Tian, [6]Wei Xu, [7]Tianhong Zhang, [8]Xue Li, [9]Lu Lu, [10]Chao Wang, [11]Shibo Jiang, [12]Keliang Liu [Full author list] | Journal of Medicinal Chemistry [missing] | DOI: 10.1021/ACS.JMEDCHEM.9B00882 [ORCID]
PubMed: 31513410 [ORCID]
| | 2019-09-25 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4 | [1]Shuai Xia, [2]Qiaoshuai Lan, [3]Jing Pu, [4]Cong Wang, [5]Zezhong Liu, [6]Wei Xu, [7]Qian Wang, [8]Huan Liu, [9]Shibo Jiang, [10]Lu Lu [Full author list] | Viruses [missing] | DOI: 10.3390/V11010056 [ORCID]
PubMed: 30646495 [ORCID]
| peptide [missing] | 2019-01-14 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Characterization by high-resolution crystal structure analysis of a triple-helix region of human collagen type III with potent cell adhesion activity | [1]Chen Hua, [2]Yun Zhu, [3]Wei Xu, [4]Sheng Ye, [5]Rongguang Zhang, [6]Lu Lu, [7]Shibo Jiang [Full author list] | Biochemical and Biophysical Research Communications [missing] | DOI: 10.1016/J.BBRC.2018.12.018 [ORCID]
PubMed: 30545625 [ORCID]
| cell adhesion [missing] | 2018-12-11 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses | [1]Wei Xu, [2]Shuai Xia, [3]Jing Pu, [4]Qian Wang, [5]Peiyu Li, [6]Lu Lu, [7]Shibo Jiang [Full author list] | Frontiers in Microbiology [missing] | DOI: 10.3389/FMICB.2018.02643 [ORCID]
PubMed: 30459739 [ORCID]
| histamine antagonist [missing]; chlorpheniramine [missing] | 2018-11-06 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Topical Application of a Vitamin A Derivative and Its Combination With Non-ablative Fractional Laser Potentiates Cutaneous Influenza Vaccination | [1]Peiyu Li, [2]Ji Wang, [3]Miao Cao, [4]Qiwen Deng, [5]Shibo Jiang, [6]Mei X Wu, [7]Lu Lu [Full author list] | Frontiers in Microbiology [missing] | DOI: 10.3389/FMICB.2018.02570 [ORCID]
PubMed: 30425691 [ORCID]
| vitamin A [missing]; vitamin [missing] | 2018-10-30 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Prospects for a MERS-CoV spike vaccine | [1]Yusen Zhou, [2]Shibo Jiang, [3]Lanying Du, [3-Q89375433]Lanying Du [Full author list] | Expert Review of Vaccines [missing] | DOI: 10.1080/14760584.2018.1506702 [ORCID]
PubMed: 30058403 [ORCID]
| | 2018-08-09 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Advances in the research and development of therapeutic antibodies against the Zika virus | [1]Shibo Jiang, [1-Q88118974]Shibo Jiang, [2]Lanying Du [Full author list] | Cellular and Molecular Immunology [missing] | DOI: 10.1038/S41423-018-0043-X [ORCID]
PubMed: 29802365 [ORCID]
| Zika virus [missing] | 2018-05-25 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors. | [1]Chao Wang, [2]Shuai Xia, [3]Peiyu Zhang, [4]Tianhong Zhang, [5]Weicong Wang, [6]Yangli Tian, [7]Guangpeng Meng, [8]Shibo Jiang, [9]Keliang Liu [Full author list] | Journal of Medicinal Chemistry [missing] | DOI: 10.1021/ACS.JMEDCHEM.7B01732 [ORCID]
PubMed: 29442512 [ORCID]
| Middle East [missing]; Middle East respiratory syndrome coronavirus [missing]; Middle East respiratory syndrome [missing] | 2018-02-14 | Shibo Jiang (Q88118974; 321 items)
|
| HIV-1 Env DNA prime plus gp120 and gp70-V1V2 boosts induce high level of V1V2-specific IgG and ADCC responses and low level of Env-specific IgA response: implication for improving RV144 vaccine regimen | [1]Qian Wang, [2]Yanyan Dai, [3]Zhiwu Sun, [4]Xiaojie Su, [5]Yufeng Yu, [6]Chen Hua, [7]Wei Xu, [8]Shibo Jiang, [9]Lu Lu [Full author list] | Emerging Microbes & Infections [missing] | DOI: 10.1038/EMI.2017.90 [ORCID]
PubMed: 29184156 [ORCID]
| | 2017-11-29 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses | [1]Xiaohuan Wang, [2]Peng Zou, [3]Fan Wu, [4]Lu Lu, [5]Shibo Jiang [Full author list] | Frontiers of medicine [missing] | DOI: 10.1007/S11684-017-0589-5 [ORCID]
PubMed: 29170916 [ORCID]
| | 2017-11-23 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Adding an Artificial Tail-Anchor to a Peptide-Based HIV-1 Fusion Inhibitor for Improvement of Its Potency and Resistance Profile | [1]Shan Su, [2]Zhenxuan Ma, [3]Chen Hua, [4]Weihua Li, [5]Lu Lu, [6]Shibo Jiang [Full author list] | Molecules [missing] | DOI: 10.3390/MOLECULES22111996 [ORCID]
PubMed: 29156603 [ORCID]
| | 2017-11-20 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses | [1]Lei-Ping Zeng, [2]Xing-Yi Ge, [3]Cheng Peng, [4]Wanbo Tai, [5]Shibo Jiang, [5-Q88118974]Shibo Jiang, [6]Lanying Du, [7]Zheng-Li Shi [Full author list] | Science in China. Series C: Life Sciences [missing] | DOI: 10.1007/S11427-017-9189-3 [ORCID]
PubMed: 29134417 [ORCID]
| SARSr-CoV [missing]; SARS-CoV-1 [missing] | 2017-11-10 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Chidamide, a histone deacetylase inhibitor-based anticancer drug, effectively reactivates latent HIV-1 provirus | [1]Wenqian Yang, [2]Zhiwu Sun, [3]Chen Hua, [4]Qian Wang, [5]Wei Xu, [6]Qiwen Deng, [7]Yanbin Pan, [8]Lu Lu, [9]Shibo Jiang [Full author list] | Microbes and Infection [missing] | DOI: 10.1016/J.MICINF.2017.10.003 [ORCID]
PubMed: 29126877 [ORCID]
| | 2017-11-08 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III | [1]Yanling Wu, [2]Shun Li, [3]Lanying Du, [4]Chunyu Wang, [5]Peng Zou, [6]Binbin Hong, [7]Mengjiao Yuan, [8]Xiaonan Ren, [9]Wanbo Tai, [10]Yu Kong, [11]Chen Zhou, [12]Lu Lu, [13]Xiaohui Zhou, [14]Shibo Jiang, [15]Tianlei Ying [Full author list] | Emerging Microbes & Infections [missing] | DOI: 10.1038/EMI.2017.79 [ORCID]
PubMed: 29018252 [ORCID]
| Zika virus [missing] | 2017-10-11 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin | [1]Fei Yu, [2]He Song, [3]Yanling Wu, [4]Soyoung Chang, [5]Lili Wang, [6]Wei Li, [7]Binbin Hong, [8]Shuai Xia, [9]Chunyu Wang, [10]Surender Khurana, ..., [21]Xinhua Ji, [22]Lu Lu, [23]Shibo Jiang, [24]Dimiter S Dimitrov, [25]Tianlei Ying [Full author list] | Cell Host & Microbe [missing] | DOI: 10.1016/J.CHOM.2017.08.011 [ORCID]
PubMed: 28966056 [ORCID]
| | 2017-09-28 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection | [1]Yan Guo, [2]Lei He, [3]Nianping Song, [4]Pei Li, [5]Shihui Sun, [6]Guangyu Zhao, [7]Wanbo Tai, [8]Shibo Jiang, [9]Lanying Du, [10]Yusen Zhou [Full author list] | Microbes and Infection [missing] | DOI: 10.1016/J.MICINF.2017.08.010 [ORCID]
PubMed: 28903071 [ORCID]
| | 2017-09-10 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Genomic signature analysis of the recently emerged highly pathogenic A(H5N8) avian influenza virus: implying an evolutionary trend for bird-to-human transmission | [1]Wei Xu, [2]Yanyan Dai, [3]Chen Hua, [4]Qian Wang, [5]Peng Zou, [6]Qiwen Deng, [7]Shibo Jiang, [8]Lu Lu [Full author list] | Microbes and Infection [missing] | DOI: 10.1016/J.MICINF.2017.08.006 [ORCID]
PubMed: 28889970 [ORCID]
| avian influenza [missing]; Influenza A virus subtype H5N8 [missing] | 2017-09-07 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity | [1]Shan Su, [2]Qian Wang, [3]Wei Xu, [4]Fei Yu, [5]Chen Hua, [6]Yun Zhu, [7]Shibo Jiang, [8]Lu Lu [Full author list] | AIDS [missing] | DOI: 10.1097/QAD.0000000000001415 [ORCID]
PubMed: 28121713 [ORCID]
| | 2017-01-24 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Enhancement of endocytic uptake of HIV-1 virions into CD4-negative epithelial cells by HIV-1 gp41 via its interaction with POB1 | [1]Yue Tan, [2]Junyi Wang, [3]Shan Su, [4]Qian Wang, [5]Shibo Jiang, [6]Lu Lu, [7]Ying-Hua Chen [Full author list] | Cellular and Molecular Immunology [missing] | DOI: 10.1038/CMI.2015.38 [ORCID]
PubMed: 28579616 [ORCID]
| virion [missing] | 2015-05-25 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Nonneutralizing Antibodies Induced by the HIV-1 gp41 NHR Domain Gain Neutralizing Activity in the Presence of the HIV Fusion Inhibitor Enfuvirtide: a Potential Therapeutic Vaccine Strategy | [1]Qian Wang, [2]Wenwen Bi, [3]Xiaojie Zhu, [4]Haoyang Li, [5]Qianqian Qi, [6]Fei Yu, [7]Lu Lu, [8]Shibo Jiang [Full author list] | Journal of Virology [missing] | DOI: 10.1128/JVI.00791-15 [ORCID]
PubMed: 25903343 [ORCID]
| therapeutic vaccine [missing] | 2015-04-22 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein | [1]Jingjing Guo, [2]Yi Yang, [3]Wenjun Xiao, [4]Weilai Sun, [5]Hong Yu, [6]Lanying Du, [7]Sara Lustigman, [8]Shibo Jiang, [9]Zhihua Kou, [10]Yusen Zhou [Full author list] | Vaccine [missing] | DOI: 10.1016/J.VACCINE.2015.02.053 [ORCID]
PubMed: 25736195 [ORCID]
| pathogenesis [missing] | 2015-02-28 | Shibo Jiang (Q88118974; 321 items)
|
| Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys | [1]Shihui Sun, [2]Guangyu Zhao, [3]Chenfeng Liu, [4]Wei Fan, [5]Xiaojun Zhou, [6]Lin Zeng, [7]Yan Guo, [8]Zhihua Kou, [9]Hong Yu, [10]Junfeng Li, [11]Renxi Wang, [12]Yan Li, [13]Conny Schneider, [14]Maria Habel, [15]Niels C Riedemann, [16]Lanying Du, [17]Shibo Jiang, [18]Renfeng Guo, [19]Yusen Zhou [Full author list] | Clinical Infectious Diseases [missing] | DOI: 10.1093/CID/CIU887 [ORCID]
PubMed: 25433014 [ORCID]
| | 2014-11-27 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry | [1]Qi Liu, [2]Shuai Xia, [3]Zhiwu Sun, [4]Qian Wang, [5]Lanying Du, [6]Lu Lu, [7]Shibo Jiang [Full author list] | Antimicrobial Agents and Chemotherapy [missing] | DOI: 10.1128/AAC.03977-14 [ORCID]
PubMed: 25331705 [ORCID]
| Middle East [missing]; Middle East respiratory syndrome coronavirus [missing]; Middle East respiratory syndrome [missing] | 2014-10-20 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Correction: HIV-1 Fusion Is Blocked through Binding of GB Virus C E2D Peptides to the HIV-1 gp41 Disulfide Loop | [1]Kristin Eissmann, [2]Sebastian Mueller, [3]Heinrich Sticht, [4]Susan Jung, [5]Peng Zou, [6]Shibo Jiang, [6-Q88118974]Shibo Jiang, [7]Andrea Gross, [8]Jutta Eichler, [9]Bernhard Fleckenstein, [10]Heide Reil, [9-Q825010]Bernhard Fleckenstein [Full author list] | PLOS One [missing] | DOI: 10.1371/ANNOTATION/B46459E1-73FF-4B75-8F24-264CBCF4A5A9 [ORCID]
| GB virus C [missing] | 2014-01-13 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development | [1]Lanying Du, [2]Guangyu Zhao, [3]Zhihua Kou, [4]Cuiqing Ma, [5]Shihui Sun, [6]Vincent K. M. Poon, [7]Lu Lu, [8]Lili Wang, [9]Asim K. Debnath, [10]Bo-Jian Zheng, [11]Yusen Zhou, [12]Shibo Jiang [Full author list] | Journal of Virology [missing] | DOI: 10.1128/JVI.02357-13 [ORCID]
| Middle East respiratory syndrome [missing]; Human coronavirus [missing] | 2013-10-03 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread | [1]Lu Lu, [2]Qi Liu, [3]Lanying Du, [4]Shibo Jiang [Full author list] | Microbes and Infection [missing] | DOI: 10.1016/J.MICINF.2013.06.003 [ORCID]
PubMed: 23791956 [ORCID]
| Middle East [missing]; respiratory tract infection [missing]; Coronaviridae [missing]; Middle East respiratory syndrome coronavirus [missing]; Middle East respiratory syndrome [missing] | 2013-06-19 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Development of SARS vaccines and therapeutics is still needed | [1]Shibo Jiang, [1-Q88118974]Shibo Jiang, [2]Lu Lu, [3]Lanying Du, [3-Q89375433]Lanying Du [Full author list] | Future Virology [missing] | DOI: 10.2217/FVL.12.126 [ORCID]
PubMed: 32201503 [ORCID]
| | 2012-12-20 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies | [1]Lanying Du, [2]Shibo Jiang [Full author list] | Future Virology [missing] | DOI: 10.2217/FVL.09.78 [ORCID]
PubMed: 32201501 [ORCID]
| immunotherapy [missing] | 2010-03-01 | Shibo Jiang (Q88118974; 321 items)
|
| Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies | [1]Zhongyu Zhu, [2]Samitabh Chakraborti, [3]Yuxian He, [4]Anjeanette Roberts, [5]Tim Sheahan, [6]Xiaodong Xiao, [7]Lisa Hensley, [8]Ponraj Prabakaran, [9]Barry Rockx, [10]Igor Sidorov, ..., [19]Gary Nabel, [20]Kanta Subbarao, [21]Shibo Jiang, [22]Dimiter S Dimitrov [Full author list] | Proceedings of the National Academy of Sciences of the United States of America [missing] | DOI: 10.1073/PNAS.0701000104 [ORCID]
PubMed: 17620608 [ORCID]
| antibody [missing]; SARSr-CoV [missing]; monoclonal antibody [missing]; Coronaviridae [missing]; SARS-CoV-1 [missing] | 2007-07-09 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|
| Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors | [1]Shuwen Liu, [2]Gengfu Xiao, [3]Yibang Chen, [4]Yuxian He, [5]Jinkui Niu, [6]Carlos R Escalante, [7]Huabao Xiong, [8]James Farmar, [9]Asim K Debnath, [10]Po Tien, [11]Shibo Jiang [Full author list] | The Lancet [missing] | DOI: 10.1016/S0140-6736(04)15788-7 [ORCID]
PubMed: 15043961 [ORCID]
| SARSr-CoV [missing]; Coronaviridae [missing]; SARS-CoV-1 [missing] | 2004-03-01 | Shibo Jiang (Q88118974; 321 items)
Shibo Jiang (Q89470665; 28 items)
|